The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.50
Bid: 14.00
Ask: 15.00
Change: -1.00 (-6.45%)
Spread: 1.00 (7.143%)
Open: 16.00
High: 14.75
Low: 14.50
Prev. Close: 15.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

Tue, 31st Mar 2020 12:21

(Alliance News) - The following is a round-up of updates by UK companies on the impact of the Covid-19 pandemic, issued on Tuesday and not separately reported by Alliance News:

----------

Synairgen PLC - respiratory drug discovery - Commences dosing of patients in trial of SNG001 - an inhaled formulation of interferon-beta-1a - in Covid-19 patients. The first patient was dosed at University Hospital Southampton. "A successful outcome from this trial in COVID-19 patients would be a very important step towards a major breakthrough in the fight against this coronavirus pandemic," said Chief Executive Officer Richard Marsden.

----------

Nichols PLC - soft drinks - Cancels final dividend for 2019 of 28.0 pence per share. Unable to give financial guidance for 2020, but expects significant impact on group's performance. Reviewing arrangements for annual general meeting.

----------

Costain Group PLC - infrastructure construction and engineering - Will not pay a final dividend for 2019, pauses construction activities in London. Reports little change in demand for consultancy services to energy, defence and aviation, while critical services provision to highway, local authority clients and water utilities to continue.

----------

FIH Group PLC - specialist services group - Expects performance for year ended March 31 to be in line with market expectations, despite tough conditions. Reduces activity significantly at Momart and Portsmouth Harbour Ferry Co. Will not recommend final dividend payment, and has reduced board salaries by 30% for three months.

----------

Kape Technologies PLC - digital security and privacy software - Reports increased demand for products due to rise in remote and home working. On track to deliver adjusted earnings before interest, taxes, depreciation and amortisation of USD35 million to USD38 million in 2020, and revenue of USD120 million to USD123 million. For 2019, adjusted Ebitda was USD14.6 million and revenue USD66.1 million.

----------

Harvest Minerals Ltd - fertilizer - No impact yet on operations, but taken steps to prevent the spread of the infection. Expects 2019 results to be published late in the second quarter of 2020.

----------

Savannah Resources PLC - energy metals - Closes all offices and all field activities and reduces staff at Mutamba mineral sands project camp in Mozambique. However has continued environment impact assessment and mine plan for Mina do Barroso lithium project in Portugal, and pre-feasibility study data review for Mutamba.

----------

Parity Group PLC - staffing and consultancy - Delays publication of 2019 results in line with UK regulator's request, but says adjusted pretax profit to be in line with expectations. Unable to give accurate forecast for 2020, but expects revenue hit due to uncertainty in public sector.

----------

Toople PLC - telecom services - All staff in UK, Durban and Poland working remotely without disruption to any key business functions. Once UK government lockdown is lifted, will move all operations to Bishop's Stortford from Slough.

----------

TMT Investments PLC - venture capital - No disruptions to company's activities, and majority of portfolio firms well positioned to withstand impact of Covid-19. However, will take up selective investment approach, meaning no significant investments to be made in coming months. In addition, 2019 results publication delayed.

----------

Xpediator PLC - freight management services - Expects to publish 2019 results in April, with revenue up 19% to GBP212 million and pretax profit above GBP5.0 million. Trading in the first three months of 2020 in line with expectations, but unable to give longer-term guidance for the year.

----------

Catenae Innovation PLC - digital media - Delays release of results, for year ended September 2019, to June 30 at latest. Expects to report loss of GBP789,565 on turnover of GBP102,549.

----------

Hardide PLC - surface coating technology - Revenue for six months ended March 31 to be 25% up from year before, as facilities in Oxfordshire, UK and Virginia, US continue operations, on strong demand from oil & gas customers.

----------

Marlowe PLC - safety and compliance services - Reports strong trading in second half ended March 31, despite challenging conditions in recent weeks. However, because of government restrictions preventing employees from accessing work sites, expects impact on performance in first quarter of new financial year.

----------

Quixant PLC - gaming and broadcast technology - Delays 2019 results to April 6, but reports 20% decline in revenue to USD92.3 million, and 41% drop in adjusted pretax profit to USD10.7 million, due to reduced demand for products. Suspends dividend payout and withdraws guidance for 2020 and beyond.

----------

Sabien Technology Group PLC - boiler-load optimisation controls - Furloughs all non-essential staff, and suspends all non-essential business functions. To continue work potential acquisition of Ptarmigan SA, with target completion within the second quarter.

----------

Appreciate Group PLC - gift cards and vouchers - Trading in 11 months to end of February in line with management expectations, but in order to preserve cash, will cancelling interim dividend payment and is reviewing bonuses. Closes all offices and fulfilment locations. To provide further update at end of April.

----------

Falanx Group Ltd - cyber security services - Reports strong trading in year ended Tuesday, expects revenue growth by 13% year-on-year to GBP5.9 million. Expects to still be able to operate effectively despite lockdowns and pandemic.

----------

Thalassa Holdings Ltd - investment holdings firm - Delays publication of 2019 results.

----------

Dewhurst PLC - electrical components manufacture - Closes operations at Dewhurst UK, but A&A and TMP to continue operations with reduced workforce. Withdraws guidance for future performance, and is reviewing dividend policy for year ending September 2020. Expects first-half results to February 29 to be GBP28 million, in line with year before.

----------

Power Metal Resources PLC - metals exploration and development - Delays final results publication to May 30 from original date of March 31. Conducts ongoing review of business operations to determine Covid-19 effect. Principal operations remain unaffected, including field work in Democratic Republic of Congo.

----------

Angle PLC - liquid biopsy - Ceases operations at Angle UK laboratories and offices. Withdraws guidance for future financial years, and plans to publish results for eight months to December 31 in May instead of April.

----------

Europa Oil & Gas Holdings PLC - UK & Ireland-focused energy development - Expects existing cash reserves to be sufficient to finance activity at Wressle field development project, ongoing farm-out activities, and reduced work programmes offshore Ireland and Morocco. However, has implemented cost -cutting measures including salary cuts, and cancellation of non-core contracts.

----------

Northern Bear PLC - building services - Expects operating profit for year ended March 31 to be between GBP2.2 million and GBP2.3 million, down from GBP3.2 million the year before. Renews existing GBP3.5 million revolving credit facility with Yorkshire Bank. Majority of businesses see construction sites close.

----------

SpaceandPeople PLC - retail licensing space marketing - Furloughs majority of staff in UK offices with effect from April 1, with similar scheme implemented in Germany. All premises in UK, Germany and India closed, and volume of business transacted has decreased significantly. Cancels proposed dividend, and cuts non-essential spend.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Apr 2024 17:06

CORRECT: No record close for FTSE 100; mixed trade in US

(Correcting day of the week in the opening sentence.)

Read more
24 Apr 2024 17:00

LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US

(Alliance News) - Stock prices in London closed lower on Thursday, with the FTSE 100's recent rally taking a pause for breath, but not after hitting another record high.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
22 Apr 2024 16:52

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells.

Read more
22 Apr 2024 06:59

Angle granted European patent for CellKeep, US patent imminent

(Sharecast News) - Liquid biopsy specialist Angle announced on Monday that it has received a European patent for its 'CellKeep' slide, as it anticipated the imminent grant of an equivalent US patent application.

Read more
22 Jan 2024 18:03

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Read more
4 Jan 2024 16:54

LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls

(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data.

Read more
4 Jan 2024 12:19

Angle shares soar following "breakthrough" cancer diagnostics results

(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services.

Read more
4 Jan 2024 12:09

LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100

(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak it suffered at the start of the year.

Read more
4 Jan 2024 10:43

AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
4 Jan 2024 08:58

LONDON MARKET OPEN: Next leads buoyant FTSE 100 amid services PMIs

(Alliance News) - Stock prices in London opened up on Thursday, amid a slew of services PMI data, including for the UK, while reacting to the latest data from China.

Read more
4 Jan 2024 07:58

Angle receives 'breakthrough results' from DNA molecular analysis

(Sharecast News) - Liquid biopsy company Angle received "breakthrough results" from DNA molecular analysis of cancer patient blood samples on Thursday, sending its shares skywards as a result.

Read more
2 Jan 2024 09:04

Angle locks in $250,000 contract with Eisai

(Sharecast News) - Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumour cell analysis in a pilot study.

Read more
2 Jan 2024 08:51

IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial

Angle PLC - Surrey, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co Ltd. Under the agreement, the two will engage in a pilot study worth USD250,000 to Angle. Angle will provide circulating-tumour-cells analysis using its Portrait HER2 assay to assess the response of breast cancer patients to Eisai's BB-1701 antibody-drug conjugate. BB-1701 targets HER2, a protein that speeds up the growth of breast cancer cells. Success in the phase two pilot study will offer the possibility for multiple follow-up studies.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.